All articles tagged with #recurrence risk
A Swedish-led clinical trial found that low-dose aspirin significantly reduces the risk of colon and rectal cancer recurrence in patients with a specific genetic mutation, highlighting its potential as an affordable, personalized treatment option for colorectal cancer.
A large study shows that a low daily dose of aspirin can reduce the risk of colorectal cancer recurrence by half in patients with specific genetic mutations, suggesting a potential for personalized post-surgery treatment, though risks and benefits must be carefully weighed.
After undergoing preventive chemotherapy following abdominal surgery, Kate Middleton's cancer treatment plan sheds light on the diverse strategies, including surgery, chemotherapy, radiotherapy, immunotherapy, and hormonal therapy, tailored based on factors such as tumor origin and spread. Surgical intervention for solid tumors aims to achieve complete removal, but recurrence risk remains a challenge, leading to the use of adjuvant and neoadjuvant therapies to eradicate residual cancer cells and facilitate less invasive surgical interventions. Ongoing advancements in cancer research offer hope for increasingly refined and tailored treatment options.